Long-term cost-effectiveness of transcatheter mitral valve repair in  HF patients with secondary mitral regurgitation.

MitraClip + guideline-directed medical therapy was cost-effective in heart failure patients with secondary mitral regurgitation in the United Kingdom, Germany, and the United States, but not in mainland China from the perspective of the national healthcare system.